Spacer
Spacer
Login to your account:
Email
Password
  Forgotten password
Spacer
Spacer
USA Map
Spacer
 
Left top
Spacer Signup Spacer
Left top
Spacer
 
Spacer
Spacer
Spacer
Spacer
Spacer
Where am I? > Home > Clinical news headlines
Help Help
Line

US Clinical Researcher Awards Program

Latest Clinical News Headlines

There was more bad news for Eli Lilly following the spectacular failure of its late-stage Alzheimer’s disease candidate, and a new question mark over the future of Cymbalta in chronic pain.

BioMarin’s stock inched up yesterday on news that it has hit the acquisition trail again gaining access to a potential new Pompe disease drug by snapping up private biotech ZyStor Therapeutics in a deal worth up to $115 million.

Shire Pharmaceuticals has announced plans to pull its hypotension drug ProAmatime from the market, following reports yesterday that US regulators are preparing to withdraw its approval

German drugmaker Bayer AG has reportedly pulled $60 million out of its wallet to settle around 150 lawsuits relating to its blood loss agent Trasylol, which was yanked from the market in 2007 on safety concerns.

Japanese groups Astellas Pharma and UMN Pharma have entered into a memorandum of understanding to co-develop and exclusively commercialise the latter’s the cell culture-based influenza vaccine programmes UMN-0501 and UMN-0502

Spacer Spacer
Spacer
Sponsors
dashes

AstraZeneca

dashes

Barnett

dashes

Benchmark Research

dashes

Johnson & Johnson

dashes

Elite Research Network

dashes

GSK

dashes

I3

dashes

Johnson & Johnson

dashes

RxTrials

dashes

Sanofi Aventis

dashes

Shire

dashes





Spacer
Spacer Border
Spacer
Spacer Home | About | Competition categories | Key dates | Enter | Nominate a Colleague | Who leads the competition? | Why should my company get involved? | Attend
Competition outside the Americas
| Who is PharmaTimes?

Contact | FAQ | Terms & Conditions | Privacy Policy | Design by DJM